Evidence map›Paper›PMID 39587727›Full record

ArticleMolecular genetics & genomic medicine2024

A Novel Synonymous Variant in SQSTM1 Causes Neurodegeneration With Ataxia, Dystonia, and Gaze Palsy Revealed by Urine-Derived Cells-Based Functional Analysis.

Shinji Masuko, Mitsuto Sato, Katsuya Nakamura, Kohei Hamanaka, Satoko Miyatake, Yuji Inaba, Tomoki Kosho, Naomichi Matsumoto, Yoshiki Sekijima

Abstract readCase Reports
In one paragraph

Article in Molecular genetics & genomic medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shinji MasukoDepartment of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan.
Mitsuto SatoDepartment of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan.
Katsuya NakamuraDepartment of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan.ORCID https://orcid.org/0000-0003-2342-1089
Kohei HamanakaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Satoko MiyatakeDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Yuji InabaDivision of Neuropediatrics, Nagano Children's Hospital, Azumino, Japan.
Tomoki KoshoCenter for Medical Genetics, Shinshu University Hospital, Matsumoto, Japan.ORCID https://orcid.org/0000-0002-8344-7507
Naomichi MatsumotoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID https://orcid.org/0000-0001-9846-6500
Yoshiki SekijimaDepartment of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan.

Funding

Health Labour Sciences Research Grant from Ministry of Health, Labour and Welfare JPMH23FC1010Japan Agency for Medical Research and Development JP23dk0207066h0001Japan Agency for Medical Research and Development JP24dk0207066h0002Japan Agency for Medical Research and Development JP24ek0109617Japan Agency for Medical Research and Development JP24ek0109648Japan Agency for Medical Research and Development JP24ek0109674Japan Agency for Medical Research and Development JP24ek0109677Japan Agency for Medical Research and Development JP24ek0109760Japan Society for the Promotion of Science JP22K15646Japan Society for the Promotion of Science JP23K27520Japan Society for the Promotion of Science JP24K02230Japan Society for the Promotion of Science JP24K10637
6 · The paper itself

Abstract

backgroundHeterozygous variants of sequestosome-1 gene (SQSTM1) have been reported in patients with various neurological disorders, whereas biallelic pathogenic variants of SQSTM1 can cause child-onset and multisystem neurodegeneration, including cerebellar ataxia, dystonia, and vertical gaze palsy (NADGP). Here, we describe two cases of NADGP in a Japanese family.

methodsWe performed clinical and genetic laboratory evaluations of the two patients and their healthy parents.

resultsBy whole-exome sequencing, we identified compound heterozygous variants in SQSTM1(NM_003900.5): c.1A>G p.(Met1?) in the initial codon, and c.969G>A, located at the 3' end of exon 6, which is novel and seemingly a synonymous but is actually a truncating variant causing aberrant splicing. An SQSTM1 protein expression assay using urine-derived cells (UDCs) demonstrated that both variants (c.1A>G and c.969G>A) were unable to induce normal splicing of premessenger RNA. Cerebellar ataxia is a characteristic manifestation of this disorder; however, brain magnetic resonance imaging studies have not shown significant cerebellar atrophy. Our patients experienced chorea during adolescence.

conclusionsOnly a few reports have highlighted the presence of chorea; however, our findings suggest that NADGP should be considered as a differential diagnosis of hereditary chorea. This study also demonstrates the utility of UDCs, obtained using noninvasive approaches, in functionally analyzing genetic diseases.

Indexed as

Cerebellar AtaxiaDystoniaOcular Motility DisordersSequestosome-1 ProteinAdultFemaleHeterozygoteHumansMaleMutationPedigreeSequestosome-1 ProteinSQSTM1 protein, humanGC‐AT intronNADGPSQSTM1UDCurine‐derived cell

Identifiers

PMID39587727
PMCPMC11588856

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.